Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Aelan Cell Technologies : Names King Jordan, Ph.D. to Its Scientific Advisory Board

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/13/2016 | 07:30pm CEST

SAN FRANCISCO, CA--(Marketwired - Jan 13, 2016) - Aelan Cell Technologies announced today the appointment of King Jordan, Ph.D. to its Scientific Advisory Board. Dr. Jordan is an Associate Professor in the School of Biology and Director of the Bioinformatics Graduate Program at the Georgia Institute of Technology.

Dr. Jordan combines academic expertise in biology and genetics with 20 years of experience in bioinformatics. His work entails the development and application of computational tools for the analysis of genome sequences, along with various 'omics' functional analyses, and he has published more than 100 papers in scientific journals such as Nature, Proceedings of the National Academy of Sciences, Nucleic Acids Research, and Bioinformatics. Additionally, Dr. Jordan has been awarded research grants from the National Institutes of Health (NIH), the National Science Foundation, the Centers for Disease Control and Prevention, the Georgia Research Alliance, and the Alfred P. Sloan Foundation.

"Dr. Jordan is a national expert in bioinformatics, and he will be an invaluable asset to our team at Aelan," said Victoria Lunyak, Ph.D., the President and CEO of Aelan. "We have worked with Dr. Jordan on research projects in the past, and we're looking forward to continuing to work with him as Aelan grows."

"Dr. Jordan brings an important scientific background in bioinformatics, as well as genomics," added Chester Aldridge, Chairman of Aelan's Board of Directors and CEO of U.S. Equity Holdings. "He also is an expert in big data analysis, something that will be critical for Aelan as the company continues to develop treatments and technologies." 

At the Georgia Institute of Technology, Dr. Jordan's laboratory conducts research in bioinformatics and genomics, focusing on the analysis of large data sets in hopes of furthering the scientific understanding of the molecular and genetic determinants of human health.

"I am very excited to join Aelan Cell Technologies as a member of its Scientific Advisory Board," Dr. Jordan said. "In past experiences working with Aelan, I have been very impressed, and I look forward to helping the company continue to expand its research and development capabilities over the coming months and years."

Dr. Jordan received a B.S. in Biology from the University of Colorado and earned his Ph.D. in Genetics from the University of Georgia, after which he trained at the National Center for Biotechnology Information at the NIH, widely considered the world's leading bioinformatics institute. Dr. Jordan has also worked to develop bioinformatics and genomics capacity outside the United States, particularly in Latin America. In 2012, he was named a Fulbright Fellow to Colombia, and he is the Co-Founder and Director of the PanAmerican Bioinformatics Institute. Additionally, Dr. Jordan serves as an external scientific advisor to BIOS -- the Colombian National Center of Bioinformatics.

In addition to his academic work, Dr. Jordan consults with industry partners to help provide custom solutions to their bioinformatics challenges through his company Genomic Informatics Consulting.

About Aelan Cell Technologies:
Aelan Cell Technologies is a San Francisco startup engaged in the research, discovery, development and commercialization of innovative biomedical technologies for the advancement of human health and longevity. With a growing intellectual property portfolio of disruptive technologies and medical tools, Aelan has assembled an experienced team -- bringing together scientific and business expertise -- to successfully lead its products through each phase of development.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2949135


© Marketwired 2016
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
10:24a VODAFONE : Golf’s new darling, Yolanda Cuba
10:24a NATIONAL SECURITY : Daily Guide must retract and apologise or - Former NCA boss
10:22a CAIRO AMMAN BANK PSC : Competition for Children’s Paintings
10:11a MEET THE EXPERTS : Do we have a new digital testing buying persona?
10:02a NOKIAN TYRES : Virtual Reality helps lure Finland's biggest tire maker to Dayton
10:02a MINISTRY OF FOREIGN AFFAIRS OF UNITED ARAB EMI : UAE Embassy in Sudan implements iftar project.
10:01a QUICK SPIN : New BMW 530i sets new sports sedan benchmark
10:00a INTERNATIONAL BUSINESS MACHINES : IBM Sells Final Part Of Vacant Somers Property
09:59a SEARS : was Amazon of the 20th century By Ron Grossman
09:59a S 11 PCL : Royals 5
Latest news
Advertisement
Hot News 
8.47%SPIRAX SARCO ENGINEERING : Sarco to buy thermal tech firm Chromalox for $415 million
2.28%ELECTRA PRIVATE EQUITY : Epiris to keep focus on UK assets after Electra split
-4.04%BA and Iberia plan third-party booking surcharge, Amadeus shares hit
3.25%Fosun, others eye Australia's Origin Energy gas assets worth $1.5 billion - sources
-4.92%SUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
Most Read News
05/27 INTERNATIONAL CONSOLIDATED AIRLNS : British Airways outage has not canceled RDU flight to London; fliers should check status
05/27 DOHA BANK : branch announces Al Dana Millionaires
05/27 Beijing bling - Hyundai plots China branding reboot after missile row
05/27 GENERAL MOTORS : Detroit Free Press Susan Tompor column
05/27 HYUNDAI MOTOR : offers free inspection service for its cars in Kingdom
Most recommended articles
05/22 NOBLE : shares tumble after S&P ratings downgrade
05/27 Beijing bling - Hyundai plots China branding reboot after missile row
05/27 Reliance Communications hit by Indian mobile price war
05/27 GENERAL MOTORS : GM says ISS advises against Greenlight share plan, board nominees
05/27 FAIRFAX FINANCIAL : to sell 12.2 pct of Indian insurer ICICI Lombard